Literature DB >> 22962880

Diagnosis and management of Lyme disease.

William F Wright1, David J Riedel, Rohit Talwani, Bruce L Gilliam.   

Abstract

Lyme disease, caused by the bacterium Borrelia burgdorferi, is the most common tick-borne illness in the United States. Transmission occurs primarily through the bite of an infected deer tick (Ixodes scapularis). Identification of an erythema migrans rash following a tick bite is the only clinical manifestation sufficient to make the diagnosis of Lyme disease in the absence of laboratory confirmation. The Centers for Disease Control and Prevention recommends a two-tier serologic testing protocol using an enzyme-linked immunosorbent assay initially, followed by the more specific Western blot to confirm the diagnosis when the assay samples are positive or equivocal. The treatment of Lyme disease is determined mainly by the clinical manifestations of the disease. Doxycycline is often the preferred agent for oral treatment because of its activity against other tick-borne illnesses. Preventive measures include avoiding areas with high tick burdens, wearing protective clothing, using tick repellants (e.g., diethyltoluamide [DEET]), performing frequent body checks and bathing following outdoor activities, and instituting environmental landscape modifications (e.g., grass mowing, deer exclusion fencing) to reduce the tick burden. Although there is controversy regarding treatment of post-Lyme disease syndrome and chronic Lyme disease, there is no biologic or clinical trial evidence indicating that prolonged antibiotic therapy is of benefit.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22962880

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  17 in total

1.  Prolonged antibiotic use induces intestinal injury in mice that is repaired after removing antibiotic pressure: implications for empiric antibiotic therapy.

Authors:  Lindsey E Romick-Rosendale; Anne Legomarcino; Neil B Patel; Ardythe L Morrow; Michael A Kennedy
Journal:  Metabolomics       Date:  2014-02       Impact factor: 4.290

2.  Rigour after gonorrhea treatment in a 55-year-old man.

Authors:  Patrick O'Byrne
Journal:  Can Fam Physician       Date:  2019-02       Impact factor: 3.275

3.  T2 Magnetic Resonance Assay-Based Direct Detection of Three Lyme Disease-Related Borrelia Species in Whole-Blood Samples.

Authors:  Jessica L Snyder; Heidi Giese; Cheryl Bandoski-Gralinski; Jessica Townsend; Beck E Jacobson; Robert Shivers; Anna M Schotthoefer; Thomas R Fritsche; Clayton Green; Steven M Callister; John A Branda; Thomas J Lowery
Journal:  J Clin Microbiol       Date:  2017-05-31       Impact factor: 5.948

4.  Technical and clinical validation of three commercial real-time PCR kits for the diagnosis of neuroborreliosis in cerebrospinal fluid on three different real-time PCR platforms.

Authors:  L Maes; T Carolus; V De Preter; S Ignoul; R Cartuyvels; L Braeken; P-J D'Huys; V Saegeman; B Kabamba; M Raymaekers
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-10-06       Impact factor: 3.267

5.  Geographical Features and Seroprevalence of Borrelia burgdorferi in Erzincan, Turkey.

Authors:  Aytekin Cikman; Merve Aydin; Baris Gulhan; Faruk Karakecili; Levent Demirtas; Ozan Arif Kesik
Journal:  J Arthropod Borne Dis       Date:  2018-12-25       Impact factor: 1.198

6.  Sensitive multiplex PCR assay to differentiate Lyme spirochetes and emerging pathogens Anaplasma phagocytophilum and Babesia microti.

Authors:  Kamfai Chan; Salvatore A E Marras; Nikhat Parveen
Journal:  BMC Microbiol       Date:  2013-12-20       Impact factor: 3.605

7.  Lyme Disease Presenting with Multiple Cranial Nerve Deficits: Report of a Case.

Authors:  Abhishek Chaturvedi; Keith Baker; Donald Jeanmonod; Rebecca Jeanmonod
Journal:  Case Rep Emerg Med       Date:  2016-08-21

Review 8.  The Potential of Omics Technologies in Lyme Disease Biomarker Discovery and Early Detection.

Authors:  Alaa Badawi
Journal:  Infect Dis Ther       Date:  2016-11-29

9.  Seroprevalence of Borrelia burgdorferi in occupationally exposed persons in the Belgrade area, Serbia.

Authors:  Dragutin Jovanovic; Sonja Atanasievska; Vesna Protic-Djokic; Uros Rakic; Elvira Lukac-Radoncic; Elizabeta Ristanovic
Journal:  Braz J Microbiol       Date:  2015-07-01       Impact factor: 2.476

10.  A Case of Early Disseminated Neurological Lyme Disease Followed by Atypical Cutaneous Manifestations.

Authors:  Vamsi Kantamaneni; Vikas Sunder; Mohammad Bilal; Scott Vargo
Journal:  Case Rep Infect Dis       Date:  2017-04-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.